Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

Sellas Life Sciences Group Inc. (NASDAQ:SLS) is a biotechnology company that develops novel cancer therapies. Its lead ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Iovance Biotherapeutics (($IOVA)) announced an update on their ongoing clinical study. Study Overview: Iovance Biotherapeutics is conducting a ...

University of Wisconsin’s Carbone Cancer Center recently announced a partnership with TAE Life Sciences, a company that ...

BeOne Medicines (($ONC)) announced an update on their ongoing clinical study. BeOne Medicines (ONC) is conducting a groundbreaking Phase 1a/1b ...

Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.

LUNGevity Foundation will lead a nationwide effort to spotlight the urgent need for early detection and disease management, research funding, and equitable access to care for people impacted by lung ...

What Sets Texas Breast Specialists Apart October is Breast Cancer Awareness Month—a time to remind women about the importance ...

20 new anticancer therapeutics, two new devices, two minimally invasive tests, AI-based tools for early detection approved by FDA. (HealthDay News) — Progress in cancer research, including approval of ...